Editas Medicine - Latest Emails, Sales & DealsNew Form 8-K for Editas Medicine, IncJanuary 13, 2025 - 8 days agoEditas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic PrioritiesJanuary 13, 2025 - 8 days agoEditas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2025 - 15 days agoNew Form 8-K for Editas Medicine, IncDecember 17, 2024 - 1 month agoNew Form 8-K for Editas Medicine, IncDecember 12, 2024 - 1 month agoEditas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two YearsDecember 12, 2024 - 1 month agoNew Form 8-K for Editas Medicine, IncDecember 10, 2024 - 1 month agoNew Form 4 for Editas Medicine, IncDecember 6, 2024 - 1 month agoNew Form 4 for Editas Medicine, IncDecember 6, 2024 - 1 month agoNew Form SC 13G/A for Editas Medicine, IncNovember 12, 2024 - 2 months agoEditas Medicine to Participate in Upcoming Investor ConferencesNovember 7, 2024 - 2 months agoNew Form SC 13G/A for Editas Medicine, IncNovember 4, 2024 - 2 months agoNew Form 10-Q for Editas Medicine, IncNovember 4, 2024 - 2 months agoNew Form 8-K for Editas Medicine, IncNovember 4, 2024 - 2 months agoEditas Medicine Announces Third Quarter 2024 Results and Business UpdatesNovember 4, 2024 - 2 months agoNew Form 8-K for Editas Medicine, IncOctober 22, 2024 - 3 months agoEditas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing TherapeuticsOctober 22, 2024 - 3 months agoEditas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of ConceptOctober 19, 2024 - 3 months agoNew Form SC 13G/A for Editas Medicine, IncOctober 18, 2024 - 3 months agoNew Form 8-K for Editas Medicine, IncOctober 4, 2024 - 3 months agoEditas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare TrustOctober 4, 2024 - 3 months agoNew Form 4 for Editas Medicine, IncSeptember 6, 2024 - 4 months agoNew Form 4 for Editas Medicine, IncSeptember 6, 2024 - 4 months agoNew Form 144 for Editas Medicine, IncAugust 29, 2024 - 4 months agoNew Form 144 for Editas Medicine, IncAugust 29, 2024 - 4 months agoEditas Medicine to Participate in Upcoming Investor ConferencesAugust 29, 2024 - 4 months agoNew Form 10-Q for Editas Medicine, IncAugust 7, 2024 - 5 months agoNew Form 8-K for Editas Medicine, IncAugust 7, 2024 - 5 months agoEditas Medicine Announces Second Quarter 2024 Results and Business UpdatesAugust 7, 2024 - 5 months agoEditas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate UpdateJuly 31, 2024 - 5 months agoNew Form 4 for Editas Medicine, IncJuly 26, 2024 - 5 months agoNew Form 4 for Editas Medicine, IncJuly 23, 2024 - 6 months agoNew Form 144 for Editas Medicine, IncJuly 18, 2024 - 6 months agoNew Form 144 for Editas Medicine, IncJuly 18, 2024 - 6 months agoNew Form SC 13G/A for Editas Medicine, IncJuly 10, 2024 - 6 months agoNew Form 8-K for Editas Medicine, IncJune 27, 2024 - 6 months agoNew Form 8-K for Editas Medicine, IncJune 14, 2024 - 7 months agoEditas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressJune 14, 2024 - 7 months agoEditas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual CongressJune 14, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 6, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 6, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncJune 3, 2024 - 7 months agoNew Form 144 for Editas Medicine, IncMay 31, 2024 - 7 months agoNew Form 8-K for Editas Medicine, IncMay 31, 2024 - 7 months agoNew Form 144 for Editas Medicine, IncMay 31, 2024 - 7 months agoNew Form 4 for Editas Medicine, IncMay 22, 2024 - 8 months agoNew Form 144 for Editas Medicine, IncMay 17, 2024 - 8 months agoNew Form 4 for Editas Medicine, IncMay 14, 2024 - 8 months agoEditas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in JuneMay 14, 2024 - 8 months agoEditas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingMay 10, 2024 - 8 months agoNew Form 10-Q for Editas Medicine, IncMay 8, 2024 - 8 months agoNew Form 8-K for Editas Medicine, IncMay 8, 2024 - 8 months agoEditas Medicine Announces First Quarter 2024 Results and Business UpdatesMay 8, 2024 - 8 months agoEditas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsMay 2, 2024 - 8 months agoEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationMay 1, 2024 - 8 months agoEditas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingApril 22, 2024 - 9 months agoNew Form DEF 14A for Editas Medicine, IncApril 16, 2024 - 9 months agoNew Form DEFA14A for Editas Medicine, IncApril 16, 2024 - 9 months agoNew Form SC 13G/A for Editas Medicine, IncApril 10, 2024 - 9 months agoNew Form 4 for Editas Medicine, IncMarch 6, 2024 - 10 months agoNew Form 4 for Editas Medicine, IncMarch 6, 2024 - 10 months agoNew Form 4 for Editas Medicine, IncMarch 6, 2024 - 10 months agoNew Form 4 for Editas Medicine, IncMarch 6, 2024 - 10 months agoNew Form 144 for Editas Medicine, IncMarch 4, 2024 - 10 months agoNew Form S-3ASR for Editas Medicine, IncFebruary 28, 2024 - 10 months agoNew Form S-8 for Editas Medicine, IncFebruary 28, 2024 - 10 months agoNew Form 10-K for Editas Medicine, IncFebruary 28, 2024 - 10 months agoNew Form 8-K for Editas Medicine, IncFebruary 28, 2024 - 10 months agoEditas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business UpdatesFebruary 28, 2024 - 10 months agoEditas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsFebruary 21, 2024 - 11 months agoNew Form SC 13G/A for Editas Medicine, IncFebruary 14, 2024 - 11 months agoNew Form SC 13G/A for Editas Medicine, IncFebruary 13, 2024 - 11 months agoEditas Medicine to Participate in Upcoming Investor ConferencesJanuary 31, 2024 - 11 months agoNew Form SC 13G/A for Editas Medicine, IncJanuary 24, 2024 - 12 months agoNew Form SC 13G/A for Editas Medicine, IncJanuary 10, 2024 - 12 months agoEditas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare ConferenceJanuary 8, 2024 - 12 months agoEditas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2024 - 12 months agoEditas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9December 13, 2023 - 13 months agoNew Form 8-K for Editas Medicine, IncDecember 13, 2023 - 13 months agoNew Form 8-K for Editas Medicine, IncDecember 11, 2023 - 13 months agoEditas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored WebinarDecember 11, 2023 - 13 months agoNew Form 4 for Editas Medicine, IncDecember 7, 2023 - 13 months agoNew Form 8-K for Editas Medicine, IncNovember 22, 2023 - 14 months ago12LatestFind More Emails, Deals & Sales From These StoresBuy DigLevin FurnitureOh La La Cheri ParisLinen SocialNail Company Wholesale SupplyEarth ShoesNUVO MagazineDemocracy ClothingHD ButtercupGlo Boutique SpaTory BurchAU RugsScout & Co KidsThe Jerusalem PostActivationProducts.comCalypso BoutiqueEastwoodClaude and Co. UKSilk And SonderRec Pro